Fluorescent magnetic nanoprobes for in vivo targeted imaging and hyperthermia therapy of prostate Cancer

Nano Biomedicine and Engineering

Volumn 1, Issue 1, 2009, Pages 61-74

  Cui, Daxiang ^a   Han, Yuedong ^b   Li, Zhiming ^c   Song, Hua ^a   Wang, Kan ^a   He, Rong ^a   Liu, Bing ^a   Liu, Heliang ^c   Bao, Chenchen ^a   Huang, Peng ^a   Ruan, Jin ^a   Gao, Feng ^a   Yang, Hao ^a   Cho, Hoon Sung ^d   Ren, Qiushi ^c   Shi, Donglu ^a,d  

^a Institute of MicroandNano Science and Technology   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Fluorescent magnetic nanoparticles; Magnetic resonance imaging; Prostate cancer; Single chain Fv antibody against seminoprotein; Sluorescent imaging

Indexed keywords

EID: 77953507216     PISSN: None     EISSN: 21505578     Source Type: Journal    
DOI: 10.5101/nbe.v1i1.p61-74     Document Type: Article

References (54)

1. Jemal A, Siegel R and Ward E. Cancer statistics. CA Cancer J Clin 2008; 58: 71-96.
2. Zeller JL. Grading of prostate cancer. JAMA 2007; 298: 1596.
3. Nie S, Xing Y, Kim GJ and Simons JW. Nanotechnology applications in cancer. Annu Rev Biomed Eng 2007; 9: 257-288.
4. Weissleder R. Molecular Imaging in cancer. Science 2006; 312: 1168-1171.
5. Lee J, Hu H, Jun Y, Seo J, Jang J, Song H, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nature Medicine 2007; 13: 95-99.
6. Holves AM, Heesakkers AM. The diagnostic accuracy of CT and MRI in the pelvis of lymph nodes in patients with prostate cancer: a meta-analysis. Adang Clin Radiol 2008; 63: 387-395.
7. Medarova Z, Pham W, Farrar C, Petkova V and Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007; 13: 372-377.
8. Kularatne SA, Zhou Z, Yang J, Post CB and Low PS. Design, synthesis and preclinical evaluation of prostate-specific membrane antigen targeted 99mTc-radioimaging agents. Molecular Pharmaceutics 2009; 6: 780-789.
9. Sasaki R, Habuchi T, Sato K, Akao T, Kakinuma H, Zhang LQ, et al. The clinical utility of measuring total PSA, PSA Density, γ-seminoprotein and γ-seminoprotein/total PSA in Prostate Cancer Prediction. Jpn J Clin Oncol 2000; 30: 337-342.
10. Yokota T, Milenic DE, Whitlow M and Schlom1 J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 1992; 52: 3402-3408.
11. Han Y, Huan Y, Deng J, Gao F, Pan B and Cui D. Expression of Single-Chain Fv Gene Specific for gama-Seminoprotein by RTS and Its Biological Activity Identification. Biotechnol Prog 2006; 22: 1084-1089.
12. Kim DH, Lee S H, Kim KN, Kim KM, Shim IB and Lee YK. Cytotoxicity of ferrite particles by MTT and agar diffusion methods for hyperthermic application. J Magn Magn Mater 2005; 293: 287-292.
13. Pan B, Cui D, Sheng Y, Gao F, He R, Li Q, et al. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res 2007; 67: 8156-8163.
14. Sincai M, Ganga D, Ganga M, Argherie D and Bica D. Antitumor effect of magnetite nanoparticles in cat mammary adenocarcinoma. J Magn Magn Mater 2005; 293: 438-441.
15. Sincai M, Ganga D, Ganga M, Argherie D and Bica D. Antitumor effect of magnetite nanoparticles in cat mammary adenocarcinoma. J Magn Magn Mater 2005; 293: 438-441.
16. Medintz IL, Uyeda HT, Goldman ER and Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nature Mater 2005; 4: 435-446.
17. Xu P, Cui D, Pan B, Gao F, He R, Li Q, et al. A facile strategy for covalent binding of nanoparticles onto carbon nanotubes. Appl Surf Sci 2008; 254: 5236-5240.
18. He R, You X, Shao J, Gao F, Pan B and Cui D. Core/shell fluorescent magnetic silica-coated composite nanoparticles for bioconjugation. Nanotechnology 2007; 18: 315601.
19. You X, He R, Gao F, Shao J, Pan B and Cui D. Nanotechnology 2007; 18: 035701.
20. Alivisatos AP. The use of nanocrystals in biological detection. Nature Biotechnology 2004; 22: 47-52.
21. Bulte JWM, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001; 19: 1141-1147.
22. Burton JB, Johnson M, Sato M, Koh SBS, Mulholland DJ, Stout D, et al. Adnovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nature Medicine 2008; 14: 882-888.
23. Cui D, Pan B, Zhang H, Wang J, Wu R, F Gao, et al. Self-assembly of carbon nanotubes and quantum dots for ultra-sensitive DNA and antigen detection. Analytical Chemistry 2008; 80: 7996-8001.
24. Cui D, Tian F, Ozkan CS, Wang M and Gao H. Effects of single wall carbon nanotubes on human HEK293 cells. Toxicology Letters 2005; 155: 73-85.
25. Cui D, Jin G, Gao T, Sun T, Tian F, Estrada GG, et al. Characterization of BRCAA1 and its novel antigen epitope identification. Cancer Epidemiology, Biomarkers & Prevention 2004; 13: 1136-1145.
26. Hilger I, Hergt R and Kaiser WA. Towards breast cancer treatment by magnetic heating. J Magn Magn Mater 2005; 293: 314-319.
27. Wang X, Gu H and Yang Z. The heating effect of magnetic fluids in an alternating magnetic field. J Magn Magn Mater 2005; 293: 334-340.
28. Park JH, Im KH, Lee SH, Kim DH, Lee DY, Lee YK, et al. Preparation and characterization of magnetic chitosan particles for hyperthermia application. J. Magn Magn Mater 2005; 293: 328-333.
29. Sharma P and Schreiber-Agus N. Mouse models of prostate cancer. Oncogene 1999; 18: 5349-5355.
30. Lee D, Khaja S, Velasquez-Castano JC, Dasari M, Sun C, Petros J, et al. In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles. Nature Mater 2007; 6: 765-769.
31. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 2003; 27: 1554-1562.
32. Hogemann D, Ntziachristos V, Josephson L and Weissleder R. High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. Bioconjug Chem 2002; 13: 116-21.
33. Ferrari M. Cancer nanotechnology: Opportunites and challenges. Nature Reviews Cancer 2005; 5: 161-171.
34. Thrall JH. Nanotechnology and Medicine. Radiology 2004; 230: 315-318.
35. 4 Composite Nanospheres for In vivo Imaging and Hyperthermia. Adv Mater 2009; 21: 1-4.
36. Rice RF. Nanomaterials show signs of toxicity. Science 2003; 300: 243.
37. Puech P, Huglo D, Petyt G, Lemaitre L, Villers A. Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography. Current Opinion in Urology 2009; 19: 168-176.
38. Herschmanh R. Molecular imaging: Looking at problems, seeing solutions. Science 2003; 302: 605-8.
39. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol 2000; 18: 410-414.
40. Jayaprakash S, Wang X, Heston WD and Kozikowski AP. Design and synthesis of a PSMA inhibitor-doxorubicin conjugate for targeted prostate cancer therapy. Chem Med Chem 2006; 1: 299-302.
41. Tilki D, Seitz M, Singer B, Irmak S, Stief C, Reich O, et al. Molecular Imaging of Tumor Blood Vessels in Prostate Cancer. Anticancer Research 2009; 29: 1823-1829.
42. Weissleder R, Bogdanov A, Neuwelt EA and Papisov M. Long-circulating iron oxides for MR imaging. Adv Drug Deliver Rev 1995; 16: 321-324.
43. Blasberg RG. Molecular imaging and cancer. Mol Cancer Ther 2003; 2: 335-343.
44. Xu RX, Povoski SP. Diffuse optical imaging and spectroscopy for cancer. Expert Rev Med Devices 2007; 4: 83-95.
45. Islam T and Josephson L. Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles. Cancer Biomarkers 2009; 5: 99-107.
46. Ntziachristos V, Yodh AG, Schnall M, and Chance B. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 2002; 4: 347-354.
47. Yang,L, Mao H, Cao Z, Wang Y, Peng X, Wang X, et al. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology 2009; 136: 1514-1525.
48. Medarova Z, Pharm W, Kim Y, and Moore A. In vivo imaging of tumor response to therapy using a dual-modality imaging strategy. Int. J. Cancer 2006; 118: 2796-2802.
49. Schroeder RPJ, van Weerden WM, Bangma C, Krenning EP and de Jong M. Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues. Methods 2009; 48: 200-204.
50. Kim SH, Lee SH, Tian H, Chen X and Park TG. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes. Journal of Drug Targeting 2009; 17: 311-317.
51. Colcher D, Bird R, Rosell M. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J. Natl. Cancer Inst 1990; 82: 1191-1197.
52. Vaupel P, Kallinowski F and Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-6455.
53. Li Z, Huang P, Zhang X, Lin J, Yang S, Liu B, et al. RGD-Conjugated Dendrimer-Modified Gold Nanorods for in vivo Tumor Targeting and Photothermal Therapy. Molecular Pharmaceutics 2010, in press.
54. Chen Z, Chen H, Meng H, Xing G, Gao X, Sun B, et al. Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol Appl Pharmacol 2008; 230: 364-71.